BOAS
B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
1226
Omega Healthcare
OHI
$12.5B
|
JD
Joshua Dennerlein
| $42.50 | $31 |
27%
downside
| Neutral |
16 Jan ‘24
1 year ago |
|
1227
Itaú Unibanco
ITUB
$76.2B
|
MP
Mario Pierry
| $7.08 | $7.27 |
3%
upside
| Buy |
16 Jan ‘24
1 year ago |
|
1228
Ventas
VTR
$31.6B
|
JD
Joshua Dennerlein
| $69.45 | $53 |
24%
downside
| Buy |
16 Jan ‘24
1 year ago |
|
1229
Webster Financial
WBS
$10.3B
|
BB
Brandon Berman
| $61.95 | $60 |
3%
downside
| Buy |
11 Jan ‘24
1 year ago |
|
1230
FNB Corp
FNB
$5.9B
|
BB
Brandon Berman
| $16.44 | $15 |
9%
downside
| Buy |
11 Jan ‘24
1 year ago |
|
1231
Integral Ad Science
IAS
$1.44B
|
OD
Omar Dessouky
| $8.69 | $19 |
119%
upside
| Buy |
11 Jan ‘24
1 year ago |
|
1232
Weibo
WB
$2.92B
|
MZ
Miranda Zhuang
| $11.91 | $10 |
16%
downside
| Underperform |
11 Jan ‘24
1 year ago |
|
1233
Vontier
VNT
$6.34B
|
AO
Andrew Obin
| $43.23 | $40 |
7%
downside
| Buy |
11 Jan ‘24
1 year ago |
|
1234
Illinois Tool Works
ITW
$77.6B
|
AO
Andrew Obin
| $266.37 | $235 |
12%
downside
| Underperform |
10 Jan ‘24
1 year ago |
|
1235
Verisk Analytics
VRSK
$37.2B
|
HB
Heather Balsky
| $266.24 | $260 |
2%
downside
| Neutral |
8 Jan ‘24
1 year ago |
|
1236
Pebblebrook Hotel Trust
PEB
$1.4B
|
SK
Shaun Kelley
| $11.81 | $13.50 |
14%
upside
| Underperform |
8 Jan ‘24
1 year ago |
|
1237
Host Hotels & Resorts
HST
$12.2B
|
SK
Shaun Kelley
| $17.68 | $23 |
30%
upside
| Buy |
8 Jan ‘24
1 year ago |
|
1238
Knife River
KNF
$4.57B
|
SE
Sherif El-Sabbahy
| $80.68 | $81 |
0%
upside
| Buy |
5 Jan ‘24
1 year ago |
|
1239
Permian Resources
PR
$9.8B
|
DL
Doug Leggate
| $13.95 | $15 |
8%
upside
| Neutral |
5 Jan ‘24
1 year ago |
|
1240
EOG Resources
EOG
$65.5B
|
DL
Doug Leggate
| $120 | $140 |
17%
upside
| Neutral |
5 Jan ‘24
1 year ago |
|
1241
Coterra Energy
CTRA
$18.6B
|
DL
Doug Leggate
| $24.37 | $31 |
27%
upside
| Buy |
5 Jan ‘24
1 year ago |
|
1242
Bristol-Myers Squibb
BMY
$96.8B
|
GM
Geoff Meacham
| $47.54 | $60 |
26%
upside
| Neutral |
3 Jan ‘24
1 year ago |
|
1243
Alkermes
ALKS
$4.57B
|
JG
Jason Gerberry
| $27.71 | $29 |
5%
upside
| Neutral |
2 Jan ‘24
1 year ago |
|
1244
Arrowhead Research
ARWR
$4.11B
|
JG
Jason Gerberry
| $29.72 | $37 |
25%
upside
| Buy |
2 Jan ‘24
1 year ago |
|
1245
Xenon Pharmaceuticals
XENE
$2.87B
|
JG
Jason Gerberry
| $37.22 | $56 |
50%
upside
| Buy |
2 Jan ‘24
1 year ago |
|
1246
GoodRx Holdings
GDRX
$1.47B
|
MC
Michael Cherny
| $4.22 | $4.50 |
7%
upside
| Underperform |
2 Jan ‘24
1 year ago |
|
1247
Brady Corp
BRC
$3.76B
|
GS
George Staphos
| $79.88 | $65 |
19%
downside
| Buy |
2 Jan ‘24
1 year ago |
|
1248
Harmony Biosciences
HRMY
$1.92B
|
JG
Jason Gerberry
| $33.42 | $30 |
10%
downside
| Underperform |
2 Jan ‘24
1 year ago |
|
|
KLRS
1249
Kalaris Therapeutics, Inc. Common Stock
KLRS
$80M
|
JZ
Jason Zemansky
| $4.28 | $23 |
437%
upside
| Underperform |
26 Dec ‘23
1 year ago |
|
1250
Liquidia Corp
LQDA
$2.32B
|
GH
Greg Harrison
| $27 | $15 |
44%
downside
| Buy |
21 Dec ‘23
1 year ago |
|